Delphi Diagnostics: Advancing endocrine therapy with gene expression algorithms for breast cancer.
VolitionRx Limited, a global epigenetics firm, develops blood tests for diagnosing and monitoring cancers, sepsis, and COVID-19.
Precipio: A leading cancer diagnostics lab, providing expert advice for optimal patient care.
Crosscope is building digital pathology workflows and AI based image analysis to assist pathologists and hospitals collaborate to fight cancers.
Innovative diagnostics company using multi-omics for cancer monitoring. Founded in 2020, based in San Francisco.
Alamar Biosciences: Pioneering early-detection cancer treatment technologies since 2018.
Foundation Medicine, Inc.: A U.S. genomics firm specializing in personalized cancer diagnostic technology.
Owl Peak Labs: Innovating cancer diagnostics and screening with imaging and ML technology.
NovAccess Global: Accelerating and investing in innovative cancer diagnostics and treatments.
CVERGENX, a Tampa-based firm, pioneers in personalized radiation therapy and advanced cancer diagnostics.
Revolutionary cancer diagnosis platform for early prognosis, detection, and drug response.
Innovative non-invasive oral cancer diagnostics using miRNA markers from cheek swabs. Founded by Dr. Guy Adami in Illinois.
Oncocyte Corporation: A US-based molecular diagnostics firm, optimizing cancer care through accelerated diagnosis and treatment.
Isommune: Pioneering in tumor-specific molecule detection for early cancer diagnosis and therapy development.
Epic Sciences: A medical diagnostics firm specializing in circulating tumor cell analysis.
Isabl offers comprehensive cancer diagnostics using whole-genome analysis for precise treatment planning.
Revolutionizing breast cancer care with swift, affordable diagnostics.
LungLife AI: A molecular diagnostics firm using AI for early detection and treatment of lung cancer.
Hawkeye: Pioneering safe, fast, affordable lung cancer screening for early detection.
Expanding precision cancer solutions in Africa through genetic diversity.
Exact Sciences Corp., a US-based firm, develops non-invasive tests for early colorectal cancer detection.
KinaSense: Advancing predictive tech for effective cancer treatment with Tyrosine Kinase Inhibitors.
Radient Pharmaceuticals Corp: Innovating in cancer diagnostics and skincare product manufacturing.
Mabcure, Inc. develops proprietary antibody technology for early cancer detection and targeted therapeutics.
xMD Diagnostics, a precision diagnostics firm in Annapolis, uses microdissection tech for cancer diagnosis.